How to buy Hepion Pharmaceuticals stock | $1.7

Hepion Pharmaceuticals, Inc is a biotechnology business based in the US. Hepion Pharmaceuticals shares (HEPA) are listed on the NASDAQ and all prices are listed in US Dollars. Hepion Pharmaceuticals employs 13 staff and has a market cap (total outstanding shares value) of 0.00.

Hepion Pharmaceuticals stock price (NASDAQ: HEPA)

Use our graph to track the performance of HEPA stocks over time.

Hepion Pharmaceuticals shares at a glance

• Key figures

Information last updated 2021-07-28.

Latest market close	$1.70
52-week range	$1.45 - $4.83
50-day moving average	$1.94
200-day moving average	$1.97
Wall St. target price	$6.33
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-50.58

Buy Hepion Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Hepion Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Hepion Pharmaceuticals, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Hepion Pharmaceuticals price performance over time

Historical closes compared with the close of $1.7 from 2021-05-28

1 week (2021-07-20)	N/A
1 month (2021-07-01)	-19.05%
3 months (2021-04-30)	-1.73%
6 months (2021-01-27)	N/A

1 year (2020-07-27)	N/A
2 years (2019-07-27)	N/A
3 years (2018-07-27)	N/A
5 years (2016-07-27)	N/A

Hepion Pharmaceuticals financials

Gross profit TTM	$0
Return on assets TTM	-18.7%
Return on equity TTM	-32.54%
Profit margin	0%
Book value	$1.52
Market capitalisation	$118.9 million

TTM: trailing 12 months

Shorting Hepion Pharmaceuticals shares

There are currently 2.4 million Hepion Pharmaceuticals shares held short by investors – that's known as Hepion Pharmaceuticals's "short interest". This figure is 65.6% up from 1.4 million last month.

There are a few different ways that this level of interest in shorting Hepion Pharmaceuticals shares can be evaluated.

Hepion Pharmaceuticals's "short interest ratio" (SIR)

Hepion Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Hepion Pharmaceuticals shares currently shorted divided by the average quantity of Hepion Pharmaceuticals shares traded daily (recently around 2.5 million). Hepion Pharmaceuticals's SIR currently stands at 0.94. In other words for every 100,000 Hepion Pharmaceuticals shares traded daily on the market, roughly 940 shares are currently held short.

However Hepion Pharmaceuticals's short interest can also be evaluated against the total number of Hepion Pharmaceuticals shares, or, against the total number of tradable Hepion Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Hepion Pharmaceuticals's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Hepion Pharmaceuticals shares in existence, roughly 30 shares are currently held short) or 0.0354% of the tradable shares (for every 100,000 tradable Hepion Pharmaceuticals shares, roughly 35 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Hepion Pharmaceuticals.

Find out more about how you can short Hepion Pharmaceuticals stock.

Hepion Pharmaceuticals share dividends

We're not expecting Hepion Pharmaceuticals to pay a dividend over the next 12 months.

Have Hepion Pharmaceuticals's shares ever split?

Hepion Pharmaceuticals's shares were split on a 1:70 basis on 2 June 2019. So if you had owned 70 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Hepion Pharmaceuticals shares – just the quantity. However, indirectly, the new 6900% higher share price could have impacted the market appetite for Hepion Pharmaceuticals shares which in turn could have impacted Hepion Pharmaceuticals's share price.

Hepion Pharmaceuticals share price volatility

Over the last 12 months, Hepion Pharmaceuticals's shares have ranged in value from as little as $1.45 up to $4.83. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Hepion Pharmaceuticals's is 1.161. This would suggest that Hepion Pharmaceuticals's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Hepion Pharmaceuticals overview

Hepion Pharmaceuticals, Inc. , a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing CRV431, a cyclophilin inhibitor that is in Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver disease. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc.

Frequently asked questions

What percentage of Hepion Pharmaceuticals is owned by insiders or institutions?
Currently 0.145% of Hepion Pharmaceuticals shares are held by insiders and 24.091% by institutions. How many people work for Hepion Pharmaceuticals?
Latest data suggests 13 work at Hepion Pharmaceuticals. When does the fiscal year end for Hepion Pharmaceuticals?
Hepion Pharmaceuticals's fiscal year ends in December. Where is Hepion Pharmaceuticals based?
Hepion Pharmaceuticals's address is: 399 Thornall Street, Edison, NJ, United States, 08837 What is Hepion Pharmaceuticals's ISIN number?
Hepion Pharmaceuticals's international securities identification number is: US4268971045 What is Hepion Pharmaceuticals's CUSIP number?
Hepion Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 21234W103